TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from InhaleRx Limited ( (AU:IRX) ) is now available.
InhaleRx Limited has announced the issuance of 1,000,000 performance rights and 500,000 options as part of its employee incentive scheme. This strategic move is aimed at enhancing employee engagement and aligning their interests with the company’s growth objectives, potentially strengthening its position in the competitive pharmaceutical market.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on the development and distribution of inhalation-based therapeutic solutions. The company is dedicated to advancing medical treatments through innovative inhalation technologies, catering to a market that seeks effective and efficient drug delivery systems.
Average Trading Volume: 206,709
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$6.32M
See more data about IRX stock on TipRanks’ Stock Analysis page.